Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Simulations Plus to Present at the LD 500 Virtual Conference

BusinessWire_EN 
0 0 31.08.20
Simulations Plus to Present at the LD 500 Virtual Conference
 

Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will be presenting at the LD 500 Virtual Conference on Wednesday, September 2, 2020, at 1:40 p.m. ET / 10:40 a.m. PT.

The presentation will be webcast live, and you may register for the Company’s presentation here. The slide presentation will be available in the Resource Center of the Simulations Plus website following the presentation. For more information about the conference, please contact Hayden IR at [email protected].

About Simulations Plus, Inc.

Simulations Plus, Inc., is a premier developer of drug discovery/development software and a leading provider of both preclinical and clinical pharmacometric consulting services for regulatory submissions and quantitative systems pharmacology models for drug-induced liver injury, drug-induced kidney injury, and nonalcoholic fatty liver disease. Our software is used to conduct drug research by major pharmaceutical, biotechnology, chemical, consumer goods companies and regulatory agencies worldwide. Our innovations in integrating new and existing science in medicinal chemistry, computational chemistry, pharmaceutical science, biology, and physiology into our software have made us the leading provider for physiologically based pharmacokinetic modeling and simulation. Visit us online www.simulations-plus.com.

Follow us on Twitter | LinkedIn | YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20200831005119/en/

Simulations Plus Stock

€34.00
4.290%
A very strong showing by Simulations Plus today, with an increase of €1.40 (4.290%) compared to yesterday's price.
Simulations Plus is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 51 € there is a positive potential of 50.0% for Simulations Plus compared to the current price of 34.0 €.
Show more
Like: 0
Share
BusinessWire_EN 
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Legal notice

Comments

Not a member yet? Sign up for free!